Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma

被引：217
作者：
Oberoi, Rajneet K. [1 ]
Parrish, Karen E. [1 ]
Sio, Terence T. [2 ]
Mittapalli, Rajendar K. [1 ]
Elmquist, William F. [1 ]
Sarkaria, Jann N. [2 ]
机构：
[1] Univ Minnesota, Coll Pharm, Dept Pharmaceut, Minneapolis, MN USA
[2] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA
来源：
NEURO-ONCOLOGY | 2016年 / 18卷 / 01期
关键词：
blood-brain barrier; drug delivery; efflux transporters; glioma; CANCER RESISTANCE PROTEIN; P-GLYCOPROTEIN ABCB1; SOLID LIPID NANOPARTICLES; CENTRAL-NERVOUS-SYSTEM; FOCUSED-ULTRASOUND; PHASE-I; TARGETED THERAPY; MEDIATED EFFLUX; DISRUPTION; GLIOMA;
D O I：
10.1093/neuonc/nov164
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Glioblastoma (GBM) is a lethal and aggressive brain tumor that is resistant to conventional radiation and cytotoxic chemotherapies. Molecularly targeted agents hold great promise in treating these genetically heterogeneous tumors, yet have produced disappointing results. One reason for the clinical failure of these novel therapies can be the inability of the drugs to achieve effective concentrations in the invasive regions beyond the bulk tumor. In this review, we describe the influence of the blood-brain barrier on the distribution of anticancer drugs to both the tumor core and infiltrative regions of GBM. We further describe potential strategies to overcome these drug delivery limitations. Understanding the key factors that limit drug delivery into brain tumors will guide future development of approaches for enhanced delivery of effective drugs to GBM.
引用
收藏
页码：27 / 36
页数：10
相关论文
共 85 条
  • [11] Bhatia Gaurav, 2013, F1000Res, V2, P96, DOI 10.12688/f1000research.2-96.v4
  • [12] Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec®) across the mouse blood-brain barrier
    Bihorel, Sebastien
    Camenisch, Gian
    Lemaire, Michel
    Scherrmann, Jean-Michel
    [J]. JOURNAL OF NEUROCHEMISTRY, 2007, 102 (06) : 1749 - 1757
  • [13] Solid lipid nanoparticles for targeted brain drug delivery
    Blasi, Paolo
    Glovagnoli, Stefano
    Schoubben, Aurelie
    Ricci, Maurizio
    Rossi, Carlo
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (06) : 454 - 477
  • [14] CONVECTION-ENHANCED DELIVERY OF MACROMOLECULES IN THE BRAIN
    BOBO, RH
    LASKE, DW
    AKBASAK, A
    MORRISON, PF
    DEDRICK, RL
    OLDFIELD, EH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) : 2076 - 2080
  • [15] Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
    Bogdahn, U.
    Hau, P.
    Stockhammer, G.
    Venkataramana, N. K.
    Mahapatra, A. K.
    Suri, A.
    Balasubramaniam, A.
    Nair, S.
    Oliushine, V.
    Parfenov, V.
    Poverennova, I.
    Zaaroor, M.
    Jachimczak, P.
    Ludwig, S.
    Schmaus, S.
    Heinrichs, H.
    Schlingensiepen, K-H
    [J]. NEURO-ONCOLOGY, 2011, 13 (01) : 132 - 142
  • [16] Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport
    Borlongan, CV
    Emerich, DF
    [J]. BRAIN RESEARCH BULLETIN, 2003, 60 (03) : 297 - 306
  • [17] The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (gleevec): Implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients
    Breedveld, P
    Pluim, D
    Cipriani, G
    Wielinga, P
    van Tellingen, O
    Schinkel, AH
    Schellens, JHM
    [J]. CANCER RESEARCH, 2005, 65 (07) : 2577 - 2582
  • [18] Disposition of everolimus in mdr1a-/1b-mice and after a pre-treatment of lapatinib in Swiss mice
    Chu, C.
    Abbara, C.
    Noel-Hudson, M. S.
    Thomas-Bourgneuf, L.
    Gonin, P.
    Farinotti, R.
    Bonhomme-Faivre, L.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2009, 77 (10) : 1629 - 1634
  • [19] Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model
    Cirpanli, Yasemin
    Allard, Emilie
    Passirani, Catherine
    Bilensoy, Erem
    Lemaire, Laurent
    Calis, Sema
    Benoit, Jean-Pierre
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 403 (1-2) : 201 - 206
  • [20] Distribution of STI-571 to the brain is limited by P-glycoprotein-mediated efflux
    Dai, HQ
    Marbach, P
    Lemaire, M
    Hayes, M
    Elmquist, WF
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 304 (03) : 1085 - 1092
123456789